Works by Tomaszewski, Joseph


Results: 29
    1
    2
    3
    4
    5

    Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors.

    Published in:
    2016
    By:
    • Kummar, Shivaani;
    • Chen, Alice;
    • Gutierrez, Martin;
    • Pfister, Thomas;
    • Wang, Lihua;
    • Redon, Christophe;
    • Bonner, William;
    • Yutzy, William;
    • Zhang, Yiping;
    • Kinders, Robert;
    • Ji, Jiuping;
    • Allen, Deborah;
    • Covey, Joseph;
    • Eiseman, Julie;
    • Holleran, Julianne;
    • Beumer, Jan;
    • Rubinstein, Larry;
    • Collins, Jerry;
    • Tomaszewski, Joseph;
    • Parchment, Ralph
    Publication type:
    journal article
    6
    7
    8
    9
    10

    Lack of toxicity of a STAT3 decoy oligonucleotide.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 983, doi. 10.1007/s00280-008-0823-6
    By:
    • Sen, Malabika;
    • Tosca, Patricia J.;
    • Zwayer, Christa;
    • Ryan, Michael J.;
    • Johnson, Jerry D.;
    • Knostman, Katherine A. B.;
    • Giclas, Patricia C.;
    • Peggins, James O.;
    • Tomaszewski, Joseph E.;
    • McMurray, Timothy P.;
    • Changyou Li;
    • Leibowitz, Michael S.;
    • Ferris, Robert L.;
    • Gooding, William E.;
    • Thomas, Sufi M.;
    • Johnson, Daniel E.;
    • Grandis, Jennifer R.
    Publication type:
    Article
    11

    Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 637, doi. 10.1007/s00280-005-1000-9
    By:
    • Glaze, Elizabeth R.;
    • Lambert, Amy L.;
    • Smith, Adaline C.;
    • Page, John G.;
    • Johnson, William D.;
    • McCormick, David L.;
    • Brown, Alan P.;
    • Levine, Barry S.;
    • Covey, Joseph M.;
    • Egorin, Merrill J.;
    • Eiseman, Julie L.;
    • Holleran, Julianne L.;
    • Sausville, Edward A.;
    • Tomaszewski, Joseph E.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18

    Vaccination with a recombinant vaccinia vaccine containing the B7-1 co-stimulatory molecule causes no significant toxicity and enhances T cell-mediated cytotoxicity.

    Published in:
    International Journal of Cancer, 2000, v. 85, n. 4, p. 508, doi. 10.1002/(SICI)1097-0215(20000215)85:4<508::AID-IJC11>3.0.CO;2-D
    By:
    • Freund, Yvonne R.;
    • Mirsalis, Jon C.;
    • Fairchild, David G.;
    • Brune, Joyce;
    • Hokama, Leslie A.;
    • Schindler-Horvat, Janice;
    • Tomaszewski, Joseph E.;
    • Hodge, James W.;
    • Schlom, Jeffrey;
    • Kantor, Judy A.;
    • Tyson, Charles A.;
    • Donohue, Susan J.
    Publication type:
    Article
    19
    20

    The statistics of phase 0 trials.

    Published in:
    Statistics in Medicine, 2010, v. 29, n. 10, p. 1072, doi. 10.1002/sim.3840
    By:
    • Rubinstein, Larry V.;
    • Steinberg, Seth M.;
    • Kummar, Shivaani;
    • Kinders, Robert;
    • Parchment, Ralph E.;
    • Murgo, Anthony J.;
    • Tomaszewski, Joseph E.;
    • Doroshow, James H.
    Publication type:
    Article
    21

    First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile.

    Published in:
    Investigational New Drugs, 2018, v. 36, n. 2, p. 230, doi. 10.1007/s10637-017-0495-3
    By:
    • Speranza, Giovanna;
    • Anderson, Larry;
    • Chen, Alice P.;
    • Do, Khanh;
    • Eugeni, Michelle;
    • Weil, Marcie;
    • Rubinstein, Larry;
    • Majerova, Eva;
    • Collins, Jerry;
    • Horneffer, Yvonne;
    • Juwara, Lamin;
    • Zlott, Jennifer;
    • Bishop, Rachel;
    • Conley, Barbara A.;
    • Streicher, Howard;
    • Tomaszewski, Joseph;
    • Doroshow, James H.;
    • Kummar, Shivaani
    Publication type:
    Article
    22
    23

    In Vitro Human Tissue Models in Risk Assessment: Report of a Consensus-Building Workshop.

    Published in:
    Toxicological Sciences, 2001, v. 59, n. 1, p. 17, doi. 10.1093/toxsci/59.1.17
    By:
    • MacGregor, James T.;
    • Collins, Jerry M.;
    • Sugiyama, Yuichi;
    • Tyson, Charles A.;
    • Dean, Jack;
    • Smith, Lewis;
    • Andersen, Melvin;
    • Curren, Rodger D.;
    • Houston, J. Brian;
    • Kadlubar, Fred F.;
    • Kedderis, Gregory L.;
    • Krishnan, Kannan;
    • Li, Albert P.;
    • Parchment, Ralph E.;
    • Thummel, Kenneth;
    • Tomaszewski, Joseph E.;
    • Ulrich, Roger;
    • Vickers, Alison E. M.;
    • Wrighton, Steven A.
    Publication type:
    Article
    24

    Compressing drug development timelines in oncology using phase '0' trials.

    Published in:
    2007
    By:
    • Kummar, Shivaani;
    • Kinders, Robert;
    • Rubinstein, Larry;
    • Parchment, Ralph E.;
    • Murgo, Anthony J.;
    • Collins, Jerry;
    • Pickeral, Oxana;
    • Low, Jennifer;
    • Steinberg, Seth M.;
    • Gutierrez, Martin;
    • Yang, Sherry;
    • Helman, Lee;
    • Wiltrout, Robert;
    • Tomaszewski, Joseph E.;
    • Doroshow, James H.
    Publication type:
    review
    25

    Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.

    Published in:
    PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0199361
    By:
    • Navas, Tony;
    • Pfister, Thomas D.;
    • Colantonio, Simona;
    • Aziz, Amina;
    • Dieckman, Lynda;
    • Saul, Richard G.;
    • Kaczmarczyk, Jan;
    • Borgel, Suzanne;
    • Alcoser, Sergio Y.;
    • Hollingshead, Melinda G.;
    • Lee, Young H.;
    • Bottaro, Donald P.;
    • Hiltke, Tara;
    • Whiteley, Gordon;
    • Takebe, Naoko;
    • Kinders, Robert J.;
    • Parchment, Ralph E.;
    • Tomaszewski, Joseph E.;
    • Doroshow, James H.
    Publication type:
    Article
    26
    27
    28
    29